PRME icon

Prime Medicine
PRME

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$6.42
61% upside
High target

3 analyst ratings

positive
1  neutral
33%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
LifeSci Capital
LifeSci Capital
100% 1-yr PRME win rate
23 Dec ‘25 25 days ago
Citigroup
Citigroup
Samantha Semenkow
11 Nov ‘25 2 months ago
Chardan Capital
Chardan Capital
Geulah Livshits
60% 1-yr PRME win rate
10 Nov ‘25 2 months ago